Labeling peptides with PET radiometals: Vulcan's forge

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 1, 2008, Pages 209-215

  Lucignani, Giovanni ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID CU 64; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID PESIN GA 67; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID PESIN GA 68; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID PESIN LU 177; 1,4,8,11 TETRAAZACYCLOTETRADECANE 1,4,8,11 TETRAACETIC ACID CU 64; 4,11 BIS(CARBOXYMETHYL) 1,4,8,11 TETRAAZABICYCLO[6.6.2]HEXADECANE CU 64; ARGINYLGLYCYLASPARTIC ACID; BOMBESIN CU 64; BOMBESIN RECEPTOR; CHELATE; COPPER 64; DOTATOC GA 68; EPHRIN RECEPTOR A2; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; MINIGASTRIN; MP 2346; OCTAPEPTIDE; OCTREOTIDE; OCTREOTIDE[1 DEXTRO PHENYLALANINE DOTA GA 68]; OCTREOTIDE[3 TYROSINE DOTA GA 68]; PEPTIDE; PROTEIN TYROSINE KINASE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

BINDING AFFINITY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG RECEPTOR BINDING; DRUG RETENTION; DRUG STABILITY; DRUG UPTAKE; GAMMA RADIATION; HUMAN; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; LIVER; MOLECULAR IMAGING; NONHUMAN; NUDE MOUSE; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; RECEPTOR BINDING; REVIEW; SCID MOUSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR DIAGNOSIS; XENOGRAFT;

ANIMALS; ANTIBODIES; HUMANS; METALS; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; STAINING AND LABELING;

EID: 36849076739     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0656-2     Document Type: Review

References (21)

1. Dijkgraaf I, Boerman OC, Oyen WJ, Corstens FH, Gotthardt M. Development and application of peptide-based radiopharmaceuticals. Anticancer Agents Med Chem 2007;7(5):543-51. Sep.
2. Wadas TJ, Wong EH, Weisman GR, Anderson CJ. Copper chelation chemistry and its role in copper radiopharmaceuticals. Curr Pharm Des 2007;13(1):3-16.
3. Chong HS, Mhaske S, Lin M, Bhuniya S, Song HA, Brechbiel MW, et al. Novel synthetic ligands for targeted PET imaging and radiotherapy of copper. Bioorg Med Chem Lett 2007;17(22):6107-10. Epub 2007 Sep 18, Nov 15.
4. Win Z, Al-Nahhas A, Rubello D, Gross MD. Somatostatin receptor PET imaging with Gallium-68 labeled peptides. Q J Nucl Med Mol Imaging 2007;51(3):244-50. Epub 2007 Apr 30, Sep.
5. 64 Cu-labeled DOTA-linker-bombesin(7-14) analogues containing different amino acid linker moieties. Bioconjug Chem 2007;18(4):1110-7. Epub 2007 May 16, Jul-Aug.
6. Sprague JE, Peng Y, Fiamengo AL, Woodin KS, Southwick EA, Weisman GR, et al. Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents. J Med Chem 2007;50(10):2527-35. Epub 2007 Apr 26, May 17.
7. 64 Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems. J Nucl Med 2007;48(8):1327-37. Epub 2007 Jul 13, Aug.
8. 64 Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues. Proc Natl Acad Sci USA 2007;104(30):12462-7. Epub 2007 Jul 12, Jul 24.
9. 86 Y-DOTA-(Pro1,Tyr4)-bombesin(1-14). Bioconjug Chem 2007;18(3):724-30. Epub 2007 Mar 23, May-Jun.
10. 64Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression. J Nucl Med 2007;48(7):1162-71. Epub 2007 Jun 15, Jul.
11. Cai W, Ebrahimnejad A, Chen K, Cao Q, Li ZB, Tice DA, et al. Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice. Eur J Nucl Med Mol Imaging 2007;in press.
12. 64 Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody. Eur J Nucl Med Mol Imaging. 2007;34(6):850-8. Epub 2007 Jan 30, Jun.
13. 68Ga-PET radiopharmacy: a generator-based alternative to 18F-radiopharmacy. Ernst Schering Res Found Workshop 2007. (62):215-42.
14. 68 Ga-labelled tracers in clinical routine? Eur J Nucl Med Mol Imaging 2007;34:978-81.
15. 68 Ga for medical application. J Nucl Med 2007;48(10):1741-8. Oct.
16. Azhdarinia A, Yang DJ, Chao C, Mourtada F. Infrared-based module for the synthesis of 68Ga-labeled radiotracers. Nucl Med Biol 2007;34(1):121-7. Jan.
17. 68 Ga-labelled peptides. Nucl Med Commun 2007;28(11):870-5. Nov.
18. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med 2007;48(4):508-18. Apr.
19. Zhang H, Schuhmacher J, Waser B, Wild D, Eisenhut M, Reubi JC, et al. DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours. Eur J Nucl Med Mol Imaging 2007;34(8):1198-208. Epub 2007 Jan 30, Aug.
20. Antunes P, Ginj M, Zhang H, Waser B, Baum RP, Reubi JC, et al. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging 2007;34(7):982-93. Epub 2007 Jan 16, Jul.
21. http://en.wikipedia.org/wiki/Vulcan_%28mythology%29